Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-094009
Filing Date
2024-08-08
Accepted
2024-08-08 16:15:46
Documents
84
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q orgo-20240630.htm   iXBRL 10-Q 1828464
2 EX-31.1 orgo-ex31_1.htm EX-31.1 14482
3 EX-31.2 orgo-ex31_2.htm EX-31.2 14998
4 EX-32.1 orgo-ex32_1.htm EX-32.1 14227
  Complete submission text file 0000950170-24-094009.txt   8565768

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT orgo-20240630.xsd EX-101.SCH 1453322
87 EXTRACTED XBRL INSTANCE DOCUMENT orgo-20240630_htm.xml XML 1446905
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Filer) CIK: 0001661181 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37906 | Film No.: 241188584
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)